IP Library › Granted Patent US 7,879,905
Granted Patent B2
US 7,879,905 · App. 11/268,968 · Granted Feb 1, 2011

5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

Assignee: Alcon, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,905
App. No.
11/268,968
Granted
Feb 1, 2011
Kind
B2
Abstract

Compositions containing 5,6,7-trihydroxyheptanoic acid and analogs and their use for treating posterior segment ocular diseases and diseases characterized by cellular hyperproliferation or angiogenesis, are disclosed.

Claims (1)

1. A method for treating persons suffering from dry AMD, which comprises administering a pharmaceutically effective amount of a compound selected from the group consisting of:

Assignments (2)
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2005
From: KLIMKO, PETER G.; HELLBERG, MARK R.; BINGAMAN, DAVID P.; GAMACHE, DANIEL A.
To: ALCON, INC.
Reel/Frame 017248/0118 →
Continuity (2)
Provisional Application 60626209 · Nov 9, 2004
Related Publication 20060099248A1 · May 11, 2006